Latest News

Newormics moves into new HQ

Newormics has expanded its base of operations into a customized, newly refurbished space in Austin, Texas. . Here, we lead you on a quick tour of the company’s new home..

READ MORE →

Newormics awarded SBIR Phase II grant from NIMH

Newormics is excited to announce it has been awarded a $2.25M Phase II SBIR grant from the National Institutes of Health/National Institute of Mental Health (NIMH) for the continued development of the company’s in vivo imaging and screening technologies.

READ MORE →

Newormics Announces Intent to Grant Utility Patent on the vivoChip by the European Patent Office

Newormics LLC, a developer of the first high-throughput, high-content screening platforms for use with in vivo small animal models, announced that the European Patent Office (EPO) intends to grant a patent covering the vivoChip® technology, the device design and use for C. elegans studies.

READ MORE →